YORK, Pa., Oct. 31, 2016 /PRNewswire/ -- Unilife Corporation
("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) announced that Rosemary A. Crane and
Duane M. DeSisto have joined the Company's Board of Directors. The Company also announced that its
annual meeting of stockholders will be held on Thursday, December 15, 2016 at 4:00 p.m. U.S. ET.
"Rose and Duane are outstanding additions to our Board," commented Mary Kate Wold, Unilife's
Board Chair. "Rose and Duane each has a proven track record of leading successful life sciences organizations. In particular,
Rose brings a wealth of leadership, sales, and marketing expertise and insights; and Duane has led the successful development of
drug delivery systems. Rose's and Duane's impressive accomplishments and experience will make them vital contributors in guiding
our growth strategy."
Ms. Crane has previously served as President and Chief Executive Officer of Epocrates, Inc., and prior to leading Epocrates,
she held senior executive positions at Johnson & Johnson, including Group Chairman, OTC & Nutritional Group, Group
Chairman, Consumer, Specialty Pharmaceuticals and Nutritionals, and Executive Vice President of Global Marketing for the
Pharmaceutical Group. Ms. Crane has also served in executive roles at Bristol-Myers Squibb, including President of U.S. Primary
Care and President of Global Marketing and Consumer Products. She presently serves as a Director of Teva Pharmaceuticals and as
Vice Chairman of the Board of Zealand Pharma A/S. Ms. Crane received her MBA from Kent State
University and her BA in Communications and English from the State University of New York.
Ms. Crane commented, "Serving on the Unilife Board is a great opportunity for me to share my experience in the life science
industry with Unilife, and I look forward to working with Unilife's Board and management team to move the Company ahead."
Mr. DeSisto served as the President and Chief Executive Officer of Insulet Corporation from 2003 to 2014, after serving as
Insulet's Acting Chief Executive Officer and Chief Financial Officer and Treasurer. Prior to his executive roles at Insulet, Mr.
DeSisto was President, Chief Executive Officer and Chief Financial Officer of PaperExchange.com, Inc., Chief Financial Officer of
FGX International Holdings Limited (formerly AAI-Foster Grant, Inc.), and Chief Financial Officer of ZOLL Medical Corporation.
Mr. DeSisto received his MBA from Bryant College and his BS from Providence
College.
"I am enthusiastic about joining Unilife at this important inflection point for the Company. I look forward to bringing my
experience in growing a successful drug delivery device organization to the Unilife team," commented Mr. DeSisto. "I am also
looking forward to working with Unilife's strong Board and talented management team as they execute on their significant market
opportunity."
"Our executive team is delighted by the additions of Rose and Duane to the Unilife Board of Directors," commented John Ryan, Unilife's President and Chief Executive Officer. "Rose and Duane each bring deep industry knowledge
and insights and executive leadership experience to Unilife, and I know they will be valuable assets in enhancing our leadership
position in the wearable injector market."
The Company's Board of Directors was assisted by John Mitchell, Global Practice Managing
Partner of Heidrick & Struggles' Healthcare and Life Sciences Practice, in conducting the search for these new Directors.
Annual Meeting of Stockholders
Unilife's annual meeting of stockholders will be held on Thursday, December 15, 2016, at
4:00 p.m., U.S. ET (8:00 a.m. AEDT on Friday,
December 16, 2016), at One Liberty Place, 1650 Market Street, Suite 2800, Philadelphia,
PA 19103. The meeting will be broadcast via the Investor Relations section of our website www.unilife.com as a "live" listen only webcast.
About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug
delivery systems. Unilife has a portfolio of innovative, differentiated products with a primary focus on wearable injectors.
Products within each platform are customizable to address specific customer, drug and patient
requirements. Unilife's global headquarters and manufacturing facilities are located in York, PA. For more
information, visit www.unilife.com.
Forward-Looking Statements
This press release contains forward-looking statements. All statements that address operating performance, events or
developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking
statements are based on management's beliefs and assumptions and on information currently available to our management. Our
management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue
reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake
any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events
or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties
that could cause actual results, events and developments to differ materially from our historical experience and our present
expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk
Factors" and elsewhere in our Annual Report on Form 10-K, those described in the "Risk Factors" set forth in Unilife's prospectus
supplement, dated as of and filed with the U.S. Securities and Exchange Commission on February 22,
2016, and those described from time to time in other reports which we file with the U.S. Securities and Exchange
Commission.
General: UNIS-G
Investor Contact (US):
Jeremy Feffer
Unilife Corporation
+1-717-384-3450
investors@unilife.com
Investor Contact (Australia):
Jeff Carter
Unilife Corporation
+61 2 8346 6500
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/unilife-appoints-rosemary-crane-and-duane-desisto-to-its-board-of-directors-unilife-announces-date-of-2016-annual-meeting-300353804.html
SOURCE Unilife Corporation